Skip to main content

MoneyWorks4Me

Shalby informs about disclosure

08 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, Shalby has informed that the Company's Wholly-owned Subsidiary Mars Medical Devices (MMDL) has further subscribed 2,09,000 equity shares of SGD 1 each in MMDL'S Subsidiary Shalby Global Technologies, Singapore (SGTPL), and remitted funds for the same on December 7, 2021. SGTPL is a subsidiary of Mars Medical Devices and a Step-down Subsidiary of the Company. Shareholding of MMDL in SGTPL is now increased from 96% to 97.82%.

The above information is a part of company’s filings submitted to BSE.


Peers